Lee S - Search Results

1

Removal of Uremic Solutes from Dialysate by Activated Carbon.

Lee S, Sirich TL, Blanco IJ, Plummer NS, Meyer TW. Lee S, et al. Clin J Am Soc Nephrol. 2022 Aug;17(8):1168-1175. doi: 10.2215/CJN.01610222. Epub 2022 Jul 14. Clin J Am Soc Nephrol. 2022. PMID: 35835518 Free PMC article.

2

Impaired Tubular Secretion of Organic Solutes in Advanced Chronic Kidney Disease.

Mair RD, Lee S, Plummer NS, Sirich TL, Meyer TW. Mair RD, et al. Among authors: lee s. J Am Soc Nephrol. 2021 Nov;32(11):2877-2884. doi: 10.1681/ASN.2021030336. Epub 2021 Aug 18. J Am Soc Nephrol. 2021. PMID: 34408065 Free PMC article.

3

Improving Clearance for Renal Replacement Therapy.

Lee S, Sirich TL, Meyer TW. Lee S, et al. Kidney360. 2021 Jul;2(7):1188-1195. doi: 10.34067/KID.0002922021. Kidney360. 2021. PMID: 35355887 Free PMC article. Review.

4

Improving Solute Clearances by Hemodialysis.

Lee S, Sirich TL, Meyer TW. Lee S, et al. Blood Purif. 2022 May 25;51(Suppl 1):1-12. doi: 10.1159/000524512. Online ahead of print. Blood Purif. 2022. PMID: 35613554 Free PMC article. Review.

5

Increasing the Clearance of Protein-Bound Solutes by Recirculating Dialysate through Activated Carbon.

Meyer TW, Lee S, Whitmer LC, Blanco IJ, Suba JK, Sirich TL. Meyer TW, et al. Among authors: lee s. Kidney360. 2023 Jun 1;4(6):e744-e750. doi: 10.34067/KID.0000000000000155. Epub 2023 May 22. Kidney360. 2023. PMID: 37211642 Free PMC article.

6

Association of obstructive sleep apnea and diurnal variation of cystatin C.

Lee S, Noh S, Lee WH. Lee S, et al. Among authors: lee wh. BMC Nephrol. 2024 Jan 29;25(1):40. doi: 10.1186/s12882-024-03472-7. BMC Nephrol. 2024. PMID: 38287274 Free PMC article.

7

Exploration of immune-modulatory effects of amivantamab in combination with pembrolizumab in lung and head and neck squamous cell carcinoma.

Lim SM, Kang SS, Kim DK, Lee SH, Synn CB, Baek S, Yang SM, Han YJ, Kim MH, Han H, Na K, Kim Y, Yun MR, Kim JH, Byeon Y, Kim YS, Lee JB, Hong MH, Curtin JC, Patel B, Bergiers I, Pyo KH, Cho BC. Lim SM, et al. Among authors: lee sh. Cancer Res Commun. 2024 Jun 25. doi: 10.1158/2767-9764.CRC-24-0107. Online ahead of print. Cancer Res Commun. 2024. PMID: 38916448

8

Cystic fibrosis pathogens persist in the upper respiratory tract following initiation of elexacaftor/tezacaftor/ivacaftor therapy.

Hilliam Y, Armbruster CR, Rapsinski GJ, Marshall CW, Moore J, Koirala J, Krainz L, Gaston JR, Cooper VS, Lee SE, Bomberger JM. Hilliam Y, et al. Among authors: lee se. Microbiol Spectr. 2024 Jun 25:e0078724. doi: 10.1128/spectrum.00787-24. Online ahead of print. Microbiol Spectr. 2024. PMID: 38916354

9

Risk factors for vancomycin treatment failure in heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia.

Yun JH, Chang E, Bae S, Jung J, Kim MJ, Chong YP, Kim S-H, Choi S-H, Lee S-O, Kim YS. Yun JH, et al. Among authors: lee s o. Microbiol Spectr. 2024 Jun 25:e0033324. doi: 10.1128/spectrum.00333-24. Online ahead of print. Microbiol Spectr. 2024. PMID: 38916352

10

Sex disparity in stroke risk among patients with insomnia: a 19-year prospective cohort study.

Jung E, Kim DK, Lee SY, Ryu HH. Jung E, et al. Among authors: lee sy. J Clin Sleep Med. 2024 Jun 25. doi: 10.5664/jcsm.11268. Online ahead of print. J Clin Sleep Med. 2024. PMID: 38916286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128,512 results

Search Page